Related Experiment Videos
Interferon-beta directly influences monocyte infiltration into the central nervous system
Sarah Floris1, Sigrid R Ruuls, Anne Wierinckx
1Department of Molecular Cell Biology, VU Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
Abstract:
Interferon-beta (IFN-beta) has beneficial effects on the clinical symptoms of multiple sclerosis (MS) patients, but its exact mechanism of action is yet unknown. We here suggest that IFN-beta directly modulates inflammatory events at the level of cerebral endothelium. IFN-beta treatment resulted in a marked reduction of perivascular infiltrates in acute experimental allergic encephalomyelitis (EAE), the rat model for MS, which was coupled to a major decrease in the expression of the adhesion molecules ICAM-1 and VCAM-1 on brain capillaries. In vitro, IFN-beta reduced the mRNA levels and protein expression of adhesion molecules of brain endothelial cell cultures and diminished monocyte transendothelial migration. Monocyte adhesion and subsequent migration was found to be predominantly regulated by VCAM-1. These data indicate that IFN-beta exerts direct antiinflammatory effects on brain endothelial cells thereby contributing to reduced lesion formation as observed in MS patients.
Insights
Interferon-beta (IFN-beta) reduces inflammation in multiple sclerosis (MS) models by directly affecting brain endothelial cells. This mechanism involves decreasing adhesion molecules and monocyte migration, contributing to reduced lesion formation in MS.
Area of Science:
- Neuroimmunology
- Cellular and Molecular Neuroscience
Background:
- Interferon-beta (IFN-beta) is a therapeutic for multiple sclerosis (MS).
- The precise mechanism of IFN-beta's action in MS remains unclear.
- Cerebral endothelial cells play a role in neuroinflammation.
Purpose of the Study:
- To investigate the direct effects of IFN-beta on cerebral endothelium.
- To determine if IFN-beta modulates inflammatory cell adhesion and migration in the brain.
Main Methods:
- Experimental allergic encephalomyelitis (EAE) rat model for MS.
- Assessment of perivascular infiltrates and adhesion molecule expression (ICAM-1, VCAM-1).
- In vitro studies using brain endothelial cell cultures and monocyte migration assays.
Main Results:
- IFN-beta treatment significantly reduced perivascular infiltrates in EAE.
- IFN-beta decreased ICAM-1 and VCAM-1 expression on brain capillaries.
- In vitro, IFN-beta reduced adhesion molecule expression and monocyte transendothelial migration, primarily via VCAM-1.
Conclusions:
- IFN-beta exerts direct anti-inflammatory effects on brain endothelial cells.
- Modulation of adhesion molecules and monocyte migration by IFN-beta contributes to reduced lesion formation in MS.
- These findings elucidate a key mechanism of IFN-beta therapy in multiple sclerosis.